ESPERITE (ESP): transfers its laboratory activity to Geneva and consequently sells its Belgium loss making subsidiary and avoids EUR 4 millions of future cash out for charges and financial costs

January 10, 2018 Group News
DL13216

As Esperite N.V. (Euronext: ESP, “Esperite” or “the Group”) is completing its strategy to concentrate its laboratory activities in its state of the art and fully certified facilities in Geneva, its Belgium subsidiary company CryoSave Labs (“CSL” or the”Company”) is left with no commercial activity and its facility in Neil has become redundant.

Amsterdam, The Netherlands – 10 January 2018

read more

Page 1 of 4012345...102030...Last »